Paperpal Prime Logo

Expert Review of Cardiovascular Therapy : Impact Factor & More

eISSN: 1744-8344pISSN: 1477-9072

Aims and Scope of Expert Review of Cardiovascular Therapy

Expert Review of Cardiovascular Therapy is a monthly peer-reviewed medical journal covering all aspects of cardiology. It was established in 2003 and is published by Informa. The journal is abstracted and indexed in Index Medicus/MEDLINE/PubMed, Embase/Excerpta Medica, EMCare, Chemical Abstracts, Scopus, and CINAHL. Less

Key Metrics

CiteScore
3.7
SJR
Q2Internal Medicine
SNIP
0.93
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Expert Review of Cardiovascular Therapy

Expert Review of Cardiovascular Therapy Journal Specifications

Overview
Publisher TAYLOR & FRANCIS INC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2003
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Expert Review of Cardiovascular Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Expert Review of Cardiovascular Therapy

Ensuring durable pulmonary vein isolation for atrial fibrillation: prevention of collateral thermal injury and lesion inconsistency
  • 8 Aug 2026
  • Expert Review of Cardiovascular Therapy
A structured approach to cardiogenic shock: integrating phenotyping, timely circulatory support, and regional care networks
  • 6 Aug 2026
  • Expert Review of Cardiovascular Therapy
Identifying patients at risk of Takotsubo syndrome during cancer treatment: a sex-based cardio-oncology review
  • 6 Aug 2026
  • Expert Review of Cardiovascular Therapy
Improving stress echocardiography-based decision pathways for coronary intervention patients: where can current and previous trials improve real-world practice?
  • 3 Aug 2026
  • Expert Review of Cardiovascular Therapy
Early changes in renal function do not appear to mediate cardiovascular risk with dapagliflozin plus semaglutide: a real-world observational hypothesis-generating cohort study
  • 3 Aug 2026
  • Expert Review of Cardiovascular Therapy
Prioritizing psychological distress reduction during pregnancy for improved cardiovascular health
  • 31 Jul 2026
  • Expert Review of Cardiovascular Therapy
Ensuring durable pulmonary vein isolation for atrial fibrillation: prevention of collateral thermal injury and lesion inconsistency
  • 8 Aug 2026
  • Expert Review of Cardiovascular Therapy
A structured approach to cardiogenic shock: integrating phenotyping, timely circulatory support, and regional care networks
  • 6 Aug 2026
  • Expert Review of Cardiovascular Therapy
Identifying patients at risk of Takotsubo syndrome during cancer treatment: a sex-based cardio-oncology review
  • 6 Aug 2026
  • Expert Review of Cardiovascular Therapy
Improving stress echocardiography-based decision pathways for coronary intervention patients: where can current and previous trials improve real-world practice?
  • 3 Aug 2026
  • Expert Review of Cardiovascular Therapy
Early changes in renal function do not appear to mediate cardiovascular risk with dapagliflozin plus semaglutide: a real-world observational hypothesis-generating cohort study
  • 3 Aug 2026
  • Expert Review of Cardiovascular Therapy
Prioritizing psychological distress reduction during pregnancy for improved cardiovascular health
  • 31 Jul 2026
  • Expert Review of Cardiovascular Therapy

FAQs on Expert Review of Cardiovascular Therapy